Rapid detection of exon 1 NRAS gene mutations using universal heteroduplex generator technology

Human Mutation

Volumn 21, Issue 2, 2003, Pages 132-137

  Belli, Carolina ^a   De Brasi, Carlos ^a   Larripa, Irene ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

ASO; Mutation detection; NRAS; Universal heteroduplex generator

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; HETERODUPLEX;

ARTICLE; CELL LINE; EXON; GENE MUTATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CODON; DNA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; GENES, VIRAL; HETERODUPLEX ANALYSIS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION; MYELODYSPLASTIC SYNDROMES; NEUROBLASTOMA; NUCLEIC ACID HETERODUPLEXES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS P21(RAS); SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR CELLS, CULTURED; VIRAL STRUCTURAL PROTEINS;

EID: 0037265918     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10160     Document Type: Article

References (30)

1. Adjei A. 2001. Blocking oncogenic ras signalling for cancer therapy. J Natl Cancer Inst 93:1062-1073.
2. Bar-Eli M, Ahuja H, Gonzalez-Cadavid N, Foti A, Cline MJ. 1989. Analysis of N-ras exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood 73:281-283.
3. Bowen DJ, Standen GR, Granville S, Bowley, Wood NAP, Bidwell J. 1997. Genetic diagnosis of factor V Leiden using heteroduplex technology. Throm Haemost 77:119-122.
4. Burvall K, Ridanpää M, Husgafvel-Pursiainen K, Önfelt A. 1993. Separation of transforming N-ras mutations in codons 12, 13 and 61 by denaturing gradient gel electrophoresis: investigation based on a set of phagemid construct. Mut Res 285:287-294.
5. Culpan D, Graham S, Wood N, Mazurier C, Gaucher C, Bidwell J. 1997. Rapid mutation screening in type 2A von Willebrand's disease using universal heteroduplex generators. Br J Haematol 96:464-469.
6. Demunter A, Ahmadian MR, Libbrecht L, Stas M, Baens M, Scheffzek K, Degreef H, de Wolf-Peeters C, van der Oord JJ. 2001. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis. Cancer Res 61:4916-4922.
7. de Souza Fernandez T, Menendez de Souza J, Macedo Silva ML, Tabak D, Abdelhay E. 1998. Correlation of N-ras point mutation with specific chromosomal abnormalities in primary myelodysplastic syndrome. Leuk Res 22:125-134.
8. Doherty T, Connell J, Stoerker J, Markham N, Shroyer AL, Shroyer KR. 1995. Analysis of clonality by PCR for phosphoglycerate kinase-1. Heteroduplex generator. Diagn Mol Pathol 4:182-190.
9. Don RH, Cox PT, Wainwrigth BJ, Baker K, Mattick JK. 1991. "Touch down" PCR to circumvent spurious priming during gene amplification. Nucleic Acid Res 19:4008.
10. Farr CJ, Saiki RK, Erlich HA, McCormick F, Marshall CJ. 1988. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 85:1629-1633.
11. Ganguly S, Murty VVVS, Samaniego F, Reuter VE, Bosl GJ, Chaganti RSK. 1990. Detection of preferential NRAS, mutation in human male germ cell tumor by the polymerase chain reaction. Gen Chrom Cancer 1:228-232.
12. Gougopoulou DM, Hippokratis K, Ergazaki M, Anagnostopoulos NI, Grigoraki V, Spandidos DA. 1996. Mutations and expression of the ras family genes in leukemias. Stem Cells 14:725-729.
13. Howarth A, Bowen DJ. 1998. Linkage analysis in hemophilia A: simultaneous genotyping of two polymorphisms of human factor VIII gene using induced heteroduplex formation. Haemophilia 4:812-819.
14. Liu P, Leong T, Quam L, Billadeau D, Kay NE, Greipp P, Kyle RA, Oken MM, Van Ness B. 1996. Activating mutations of N- and K-Ras in multiple myeloma show different clinical associations analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood 88:2699-2706.
15. Lyons J, Johannes WG, Janssen J, Bartram C, Layton M, Mufti G. 1988. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood 71:1707-1712.
16. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S. 1994. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248-2254.
17. Mufti J. 1996. RAS and myelodysplasia: lessons from the last decade. Sem Haemat 33:206-224.
18. Mulder MP, Keijzer W, Verkerk A, Boot AJM, Prins EF, Splinter TAW, Bos JL. 1989. Activated ras genes in human seminoma: evidence for tumour heterogeneity. Oncogenes 4:1345-1351.
19. Neri A, Knowles D, Greco A, McCormick F, Dalla-Favera R. 1988. Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA 85:9268-9272.
20. Paquette R, Landaw E, Pierre R, Kaham J, Lubbert M, Lazcano O, Isaac G, McCormick F, Koeffler H. 1993. N-RAS mutations are associated with poor prognoses and increased risk of leukemia in myelodysplastic syndrome. Blood 82:590-596.
21. Rose NC, Hurwitz C, Silberstein L, Andovalu R, Stoerker J. 1997. Prenatal analysis of rhesus CcDEe blood groups by heteroduplex generator. Am J Obstet Gynecol 176:1084-1089.
22. Sambrook J, Fristch EF, Maniatis T 1989. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor University Press.
23. Savage DA, Wood NAP, Bidwell JL, Fitches A, Old JM, Hui KM. 1995. Detection of Beta-thalassaemia mutations using DNA heteroduplex generator molecules. Br J Haematol 90:564-571.
24. Savage DA, Tang JP, Wood NAP, Evans J, Bidwell JL, Wee JLK, Oei AA, Hui KM. 1996. A rapid HLA-DRB1'04 subtyping method using PCR and DNA heteroduplex generator. Tissue Antigens 47:284-292.
25. Scheele LS, Räpple D, Lübbert M. 2000. The role of Ras and other low molecular weight guanine nucleotide (GTP)-binding proteins during hematopoietic cell differentiation. (Review.) Cell Mol Life Sci 57:1950-1963.
26. Sheng XM, Kawamura M, Ohnishi H, Ida K, Hanada R, Kojima S, Kobayashi M, Bessho F, Yanagisawa M, Hayashi Y. 1997. Mutations of ras genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia. Leuk Res 21:697-701.
27. Stirewalt DL, Kopecky KJ, Meshinchi S, Appelbaum FR, Slovak ML, Willman CL, Radich JP. 2001. FLT3, RAS and TP53 mutations in elderly patients with acute myeloid leukemia. Blood 97:3589-3595.
28. Verlaan de Vries M, Bogaard ME, Van den Elst H, Van Boom JH, Van der Eb AJ, Bos JL. 1986. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligonucleotides. Gene 50:313-320.
29. Wood N, Standem G, Hows J, Bradley B, Bidwell J. 1993. Diagnosis of sickle-cell disease with a universal heteroduplex generator. Lancet 342:1519-1520.
30. Wood N, Standem G, Murray EW, Lillicrap D, Holmberg L, Peake IR, Bidwell J. 1995. Rapid genotype analysis in type 2B von Willebrand's disease using a universal heteroduplex generators. Br J Haematol 89:152-156.